Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Beef for brain health? new study tests daily steak against dementia markers

NCT ID NCT07623785

First seen Jun 04, 2026 · Last updated Jun 23, 2026 · Updated 3 times

Summary

This study is testing whether eating 5.5 ounces of lean beef every day for two weeks can improve blood markers linked to brain health in adults aged 65 and older. Twenty healthy older adults will eat beef for one phase and a non-beef protein source for another, with blood, urine, and stool samples collected to measure changes. The goal is to see if a simple food like beef can help protect against age-related cognitive decline.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY AGING are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • South Dakota State University

    RECRUITING

    Brookings, South Dakota, 57007, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

lean beef

What this could lead to

If it works, this could point toward a simple dietary change to help preserve memory and brain function in older adults.

What could go wrong

This is a very small, short-term study with only 20 participants. It looks at blood markers, not actual memory or thinking ability, so any benefits are uncertain.

Conditions

The condition(s) this trial relates to.

Plaque, Amyloid

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.